Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: While there is robust evidence of elevated dopamine synthesis capacity once a psychotic disorder has developed, little is known about whether it is altered prior to the first episode of frank illness. The authors addressed this issue by measuring dopamine synthesis capacity in individuals at ultra-high risk of psychosis and then following them to determine their clinical outcome. METHOD: This prospective study included 30 patients who met standard criteria for being at ultra-high risk of psychosis and 29 healthy volunteers. Participants were scanned using [(18)F]6-fluoro-L-dopa positron emission tomography. The ultra-high-risk patients were scanned at presentation and followed up for at least 3 years to determine their clinical outcome. Six patients had comorbid schizotypal personality disorder and were excluded from the analysis (data are provided for comparison). Of the remaining patients, nine developed a psychotic disorder (psychotic transition group) and 15 did not (nontransition group). RESULTS: There was a significant effect of group on striatal dopamine synthesis capacity. The psychotic transition group had greater dopamine synthesis capacity in the striatum (effect size=1.18) and its associative subdivision (effect size=1.24) than did the healthy comparison subjects and showed a positive correlation between dopamine synthesis capacity and symptom severity. Dopamine synthesis capacity was also significantly greater in the psychotic transition group than in the nontransition group. CONCLUSIONS: These findings provide evidence that the onset of frank psychosis is preceded by presynaptic dopaminergic dysfunction. Further research is needed to determine the specificity of elevated dopamine synthesis capacity to particular psychotic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Dopamine synthesis capacity is greater in individuals who later transition to psychosis than those who do not transition (63),”
From Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Self-citationMapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States
Yung, A. R., Yung, A. R., Pan Yuen, H., Mcgorry, P. D., Phillips, L. J., Kelly, D., Dell'olio, M., Francey, S. M., Cosgrave, E. M., Killackey, E., et al. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01714.x · Cited by 2,196
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003) · Human Brain Mapping · doi:10.1002/hbm.10123 · Cited by 1,286
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Self-citationReduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F. (2002) · Nature Neuroscience · doi:10.1038/nn804 · Cited by 652
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
Pycock, C. J., Kerwin, R. W., & Carter, C. J. (1980) · Nature · doi:10.1038/286074a0 · Cited by 549
The Pathophysiology of Schizophrenia Disorders: Perspectives From the Spectrum
Siever, L. J., & Davis, K. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.398 · Cited by 509
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
Laruelle, M., & Abi-Dargham, A. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300405 · Cited by 461
Dopaminergic dysfunction in schizophrenia: Salience attribution revisited
Heinz, A., & Schlagenhauf, F. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq031 · Cited by 412
Do we still believe in the dopamine hypothesis? New data bring new evidence
Abi-Dargham, A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004110 · Cited by 361
Yung, A. R., Nelson, B., Stanford, C., Simmons, M. B., Cosgrave, E. M., Killackey, E., Phillips, L. J., Bechdolf, A., Buckby, J., & McGorry, P. D. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.012 · Cited by 358
Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals
Sun, D., Phillips, L., Velakoulis, D., Yung, A., McGorry, P. D., Wood, S. J., van Erp, T. G. M., Thompson, P. M., Toga, A. W., Cannon, T. D., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.11.026 · Cited by 296
Howes, O., Bose, S., Turkheimer, F., Valli, I., Egerton, A., Stahl, D., Valmaggia, L., Allen, P., Murray, R., & McGuire, P. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.20 · Cited by 292
Self-citationRakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., & Brooks, D. J. (1999) · Brain · doi:10.1093/brain/122.9.1637 · Cited by 270
Howes, O., Egerton, A., Allan, V., McGuire, P., Stokes, P., & Kapur, S. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788957528 · Cited by 239
Self-citationFusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Grasby, P. M., & McGuire, P. K. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.77 · Cited by 234
Self-citationDr. Siever and Colleagues Reply
SIEVER, L. J., KEEFE, R., BERNSTEIN, D. P., COCCARO, E. F., KLAR, H. M., ZEMISHLANY, Z., PETERSON, A., DAVIDSON, M., MAHON, T., HORVATH, T., et al. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.1097 · Cited by 232
Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Montgomery, A. J., Grasby, P. M., & McGuire, P. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.108 · Cited by 207
Self-citationBertolino, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00096-2 · Cited by 174
Cannabis-Induced Psychosis-Like Experiences Are Associated with High Schizotypy
Barkus, E. J., Stirling, J., Hopkins, R. S., & Lewis, S. (2006) · Psychopathology · doi:10.1159/000092678 · Cited by 167
Structured Clinical Interview for DSM-IV (SCID)
Glasofer, D. R., Brown, A. J., & Riegel, M. (2017) · Springer eBooks · doi:10.1007/978-981-287-104-6_80 · Cited by 154
Stone, J. M., Howes, O. D., Egerton, A., Kambeitz, J. P., Allen, P., Lythgoe, D. J., Tuura, R., McLean, M. A., Barker, G. J., & McGuire, P. K. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.034 · Cited by 152
Self-citationHowes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Grasby, P. M., & Mcguire, P. K. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.191.51.s13 · Cited by 142
Self-citationPET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
Kumakura, Y., & Cumming, P. (2009) · The Neuroscientist · doi:10.1177/1073858409338217 · Cited by 134
Egerton, A., Demjaha, A., McGuire, P., Mehta, M. A., & Howes, O. D. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.058 · Cited by 134
Self-citationAbi-Dargham, A., Kegeles, L. S., Zea-Ponce, Y., Mawlawi, O., Martinez, D., Mitropoulou, V., O'Flynn, K., Koenigsberg, H. W., Van Heertum, R., Cooper, T., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.018 · Cited by 128
CSF homovanillic acid in schizotypal personality disorder
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.1.149 · Cited by 83
Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging
Bose, S. K., Turkheimer, F., Howes, O. D., Mehta, M. A., CUNLIFFE, R., Stokes, P. R. A., & Grasby, P. M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.011 · Cited by 79
Self-citationMorphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia
Binkofski, F., Reetz, K., Gaser, C., Hilker, R., Hagenah, J., Hedrich, K., van Eimeren, T., Thiel, A., Büchel, C., Pramstaller, P. P., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000267844.72421.6c · Cited by 79
Molecular Brain Imaging and the Neurobiology and Genetics of Schizophrenia
(2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45123 · Cited by 53
Multi-resolution Bayesian regression in PET dynamic studies using wavelets
Turkheimer, F., Aston, J. A. D., Asselin, M., & Hinz, R. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.03.002 · Cited by 42
Self-citationPlasma homovanillic acid in schizotypal personality disorder
Siever, L. J., D, F. A. M., Coccaro, E. F., Bernstein, D. P., Kavoussi, R. J., Kalus, O., Horvath, T., Warne, P., Davidson, M., & Davis, K. L. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1246 · Cited by 37
Chrapusta, S. J., Egan, M. F., Wyatt, R. J., Weinberger, D. R., & Lipska, B. K. (2003) · Synapse · doi:10.1002/syn.10179 · Cited by 35
Research works printed but not linked: 1
- American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Association Press Washington DC Fourth edition
Cited by
The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483
Self-citationMcCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3360 · Cited by 1,481
Self-citationHowes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Self-citationSchizophrenia: an integrated sociodevelopmental-cognitive model
Howes, O. D., & Murray, R. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62036-x · Cited by 864
Self-citationNeurodevelopmental model of schizophrenia: update 2012
Rapoport, J. L., Giedd, J. N., & Gogtay, N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.23 · Cited by 790
Metadata
- Authors
- Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P.
- Affiliations
- King's College London (GB)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2011-12
- Volume
- 168
- Issue
- 12
- Pages
- 1311-1317
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3682447
- OpenAlex
- W2143870537
- Cited by
- 343
- References
- 40
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 16 · 2023: 17 · 2022: 24 · 2021: 17 · 2020: 29 · 2019: 30 · 2018: 20 · 2017: 22 · 2016: 37 · 2015: 21 · 2014: 27 · 2013: 31 · 2012: 26
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- South London and Maudsley NHS Foundation Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine synthesis capacity, clinical high risk for psychosis, first-episode psychosis, striatum, 18F-DOPA PET, symptom severity, schizophrenia, schizotypal personality disorder
- MeSH terms
- Adult, Brain, Corpus Striatum, Dopamine, Female, Humans, Male, Prospective Studies, Psychotic Disorders, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.